EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax

Caryn Louise D Gutierrez, Anne Kristine H Quero-Taggaoa, Timothy Carl F Uy, Januario Antonio D Veloso

Journal of Medical Cases · 2026-04 · 17 (4) · 146-152

DOI: 10.14740/jmc5237 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Medical Cases, 2026-04. Verfasst von Caryn Louise D Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology, Philippine General Hospital, Manila, Philippines. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chronic lymphocytic leukemiaFixed-duration therapyHigh-risk CLLReduced dosageResource-limited settingTargeted therapyYoung adult

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Hematology, Philippine General Hospital, Manila, Philippines.
  • Department of Pathology and Laboratory Medicine, Philippine General Hospital, Manila, Philippines.

Zitieren

APA

Gutierrez, C. L. D., Quero-Taggaoa, A. K. H., Uy, T. C. F., & Veloso, J. A. D. (2026). High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. Journal of Medical Cases, 17(4), 146-152. https://doi.org/10.14740/jmc5237

Vancouver

Gutierrez CLD, Quero-Taggaoa AKH, Uy TCF, Veloso JAD. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. Journal of Medical Cases. 2026;17(4):146-152. doi:10.14740/jmc5237

BibTeX
@article{Gutierrez2026,
  author = {Gutierrez, Caryn Louise D and Quero-Taggaoa, Anne Kristine H and Uy, Timothy Carl F and Veloso, Januario Antonio D},
  title = {High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax},
  journal = {Journal of Medical Cases},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {146--152},
  doi = {10.14740/jmc5237}
}
Kostenlos starten →